Medicare Part D and Medicaid coverage are also available, depending on state-specific guidelines
Potential risks include: Elevated blood pressure (hypertension) both drug classes can raise systolic and diastolic blood pressure independently
The device can also help standardize the injection sequence by automating needle insertion and dose delivery
This excessive mitochondrial activity could potentially lead to mitochondrial dysfunction
In LEADER, 9,340 high risk T2DM patients (81.3% with a prior CV event and 18.7% with multiple CV risk factors) were randomized to liraglutide, 1.2 mg/day (which subsequently was uptitrated to 1.8 mg/day in the majority of subjects), or placebo
If intake is accurate and the plateau persists, your prescriber may increase the dose to 2.4mg weekly (if not already at max) or switch to tirzepatide for dual GIP/GLP-1 agonism